Related Experiment Video
Updated: Feb 1, 2026

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
Apigetrin treatment attenuates LPS-induced acute otitis media though suppressing inflammation and oxidative stress
Hao Guo1, Ming Li2, Li-Juan Xu1
1Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China.
Insights
Apigetrin (APT) effectively reduces inflammation and oxidative stress in acute otitis media. This natural compound shows promise in preventing and treating this common childhood ear infection by targeting key inflammatory pathways.
Area of Science:
- Pharmacology
- Immunology
- Otolaryngology
Background:
- Acute otitis media (AOM) is a common childhood illness, often self-limiting but sometimes recurrent.
- Effective preventative strategies for AOM are needed, especially given the potential for recurrent or persistent infections.
- Apigetrin (APT), a flavonoid from herbal medicines, has known anti-inflammatory and anti-oxidative properties.
Purpose of the Study:
- To investigate the efficacy of Apigetrin (APT) in ameliorating acute otitis media (AOM) in a mouse model.
- To elucidate the anti-inflammatory and anti-oxidative mechanisms of APT in LPS-induced otitis media.
- To assess APT's potential as a therapeutic candidate for AOM.
Main Methods:
- An acute otitis media mouse model was established using lipopolysaccharide (LPS) injection into the middle ear.
- Hematoxylin and eosin (H&E) staining was used to assess mucosal thickness.
- Western blot analysis was employed to evaluate the expression of key proteins in the TLR4/NF-κB pathway and oxidative stress markers.
- Levels of inflammatory cytokines and reactive oxygen species (ROS) were measured.
Main Results:
- APT treatment significantly reduced LPS-induced middle ear mucosa thickness and inflammatory cell infiltration (neutrophils, macrophages).
- APT inhibited the expression of pro-inflammatory cytokines (IL-1β, TNF-α, IL-6, VEGF) and key signaling molecules in the TLR4/NF-κB pathway.
- APT reduced LPS-induced ROS production by promoting antioxidant enzyme activity (SOD, HO-1, NQO-1) and Nrf2 expression, while decreasing MDA levels.
- In vitro studies confirmed APT's anti-inflammatory and anti-oxidative effects with minimal cytotoxicity.
Conclusions:
- Apigetrin (APT) demonstrates significant therapeutic potential in ameliorating acute otitis media.
- APT exerts its protective effects by inhibiting inflammation and oxidative stress via the TLR4/NF-κB and Nrf2 pathways.
- APT is a promising candidate for the prevention and treatment of acute otitis media in children.
Abstract:
The natural course of otitis media in children is acute and self-limiting. Nevertheless, about 10-20% children could experience recurrent or persistent otitis media. Thus, finding effective candidate to prevent acute otitis media is urgently required. In our study, mouse acute otitis media model was constructed by lipopolysaccharide (LPS) injection into the middle ear of mice via the tympanic membrane. Apigetrin (APT) is a flavonoid isolated from various herbal medicines, possessing anti-inflammatory and anti-oxidative bioactivities. However, if APT could attenuate acute otitis media in LPS-induced animal models, little is to be known. Hematoxylin and eosin (H&E) staining suggested that APT treatment reduced LPS-induced higher mucosa thickness. LPS-triggered inflammatory response was also inhibited by APT, as evidenced by the down-regulated neutrophils and macrophages. Additionally, the reduced inflammatory factors, including interleukin-1β (IL-lβ), tumor necrosis factor α (TNF-α), IL-6 and vascular endothelial growth factor (VEGF) were observed in APT-treated mice with acute otitis media. The process was associated with the inhibition of toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) pathway, which was proved by the blockage of TLR4, MyD88, p-IKKα, p-IκBα, and p-NF-κB using western blot analysis. Moreover, the production of reactive oxygen species (ROS) caused by LPS was also reduced by APT through promoting anti-oxidants, involving superoxide dismutase (SOD) activity, heme oxygenase-1 (HO-1), NADP(H) quinone oxidoreductase 1 (NQO-1) and nuclear factor erythroid 2-related factor 2 (Nrf2) expressions. In contrast, high levels of MDA and kelch-like ECH-associated protein 1 (Keap 1) in LPS-treated mice were down-regulated by APT, which might be associated with the inactivation of NF-κB. In vitro, APT exhibited anti-inflammatory and anti-oxidant effects with little cytotoxicity in LPS-stimulated cells. Together, the data above indicated that APT could ameliorate acute otitis media through inhibiting inflammation and oxidative stress.
Related Concept Videos
Inflammation
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Oxidation Numbers
Pyruvate Oxidation
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
Oxidation-Reduction Reactions
Microbial Growth Media

